Clinical Trial Update: A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) [Phase 2]

View source ↗

Summary

Phase IIb randomized, multicenter trial evaluating subretinal CPCB-RPE1 for advanced dry age-related macular degeneration with geographic atrophy; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• CPCB-RPE1

Snippet

Sponsor: Regenerative Patch Technologies, LLC | Conditions: Dry Age-related Macular Degeneration, Geographic Atrophy | Phase 2 | Status: RECRUITING